Androgen	O
receptor	O
repression	O
of	O
gonadotropin	O
-	O
releasing	O
hormone	O
gene	O
transcription	O
via	O
enhancer	O
1	O
.	O


Gonadotropin	O
-	O
releasing	O
hormone	O
(	O
GnRH	O
)	O
plays	O
a	O
major	O
role	O
in	O
the	O
hypothalamic	O
-	O
pituitary	O
-	O
gonadal	O
(	O
HPG	O
)	O
axis	O
,	O
and	O
synthesis	O
and	O
secretion	O
of	O
GnRH	O
are	O
regulated	O
by	O
gonadal	O
steroid	O
hormones	O
.	O


Disruptions	O
in	O
androgen	O
levels	O
are	O
involved	O
in	O
a	O
number	O
of	O
reproductive	O
defects	O
,	O
including	O
hypogonadotropic	O
hypogonadism	O
and	O
polycystic	O
ovarian	O
syndrome	O
.	O


Androgens	O
down	O
-	O
regulate	O
GnRH	O
mRNA	O
synthesis	O
in	O
vivo	O
and	O
in	O
vitro	O
via	O
an	O
androgen	O
receptor	O
(	O
AR	O
)	O
-	O
dependent	O
mechanism	O
.	O


Methyltrienolone	O
(	O
R1881	O
)	O
,	O
a	O
synthetic	O
AR	O
agonist	O
,	O
represses	O
GnRH	O
expression	O
through	O
multiple	O
sites	O
in	O
the	O
proximal	B-PROMOTER
promoter	E-PROMOTER
.	O


In	O
this	O
study	O
,	O
we	O
show	O
AR	O
also	O
represses	O
GnRH	O
transcription	O
via	O
the	O
major	O
enhancer	O
(	O
GnRH	O
-	O
E1	O
)	O
.	O


A	O
multimer	O
of	O
the	O
-	O
1800	O
/	O
-	O
1766	O
region	O
was	O
repressed	O
by	O
R1881	O
treatment	O
.	O


Mutation	O
of	O
two	O
bases	O
,	O
-	O
1792	O
and	O
-	O
1791	O
,	O
resulted	O
in	O
decreased	O
basal	O
activity	O
and	O
a	O
loss	O
of	O
AR	O
-	O
mediated	O
repression	O
.	O


AR	O
bound	O
to	O
the	O
-	O
1796	O
/	O
-	O
1791	O
sequence	O
in	O
electrophoretic	O
mobility	O
shift	O
assays	O
,	O
indicating	O
a	O
direct	O
interaction	O
with	O
DNA	O
or	O
other	O
transcription	O
factors	O
in	O
this	O
region	O
.	O


We	O
conclude	O
that	O
AR	O
repression	O
of	O
GnRH	O
-	O
E1	O
acts	O
via	O
multiple	O
AR	O
-	O
responsive	O
regions	O
,	O
including	O
the	O
site	O
at	O
-	O
1792	O
/	O
-	O
1791	O
.	O
